Development and Evaluation of Nanostructured Lipid Carriers for Transdermal Delivery of Ketoprofen

Yıl 2023, Cilt: 48 Sayı: 1, 105 - 124, 01.03.2023

Thulasi Sathyanarayana Preethı Sudheer , Elsa Jacob Merlin Mary Sabu

https://doi.org/10.55262/fabadeczacilik.1126288

Öz

Purpose: Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) which when administered via an oral route displays significant gastro-intestinal side effects and has low skin permeation profile. The objective of the present work is to utilise nanostructured lipid carriers (NLCs) as carrier system for transdermal delivery of ketoprofen.
Methods: NLCs were prepared via hot homogenisation technique using bees wax, carnauba wax, glycerl monostearate (solid lipids), linseed oil (liquid lipid) and poloxamer188 (surfactant) and optimized using custom design via JMP. The responses evaluated were drug entrapment efficiency, particle size and drug release profile. The experimental design was evaluated for model fit with the assistance of ANOVA. The optimum formulations were characterized for particle size, zeta potential, SEM, DSC, FTIR and also drug content, entrapment efficiency, in- vitro drug release, ex-vivo drug release profile was studied.
Results: The drug entrapment in the range of 34±0.03-95.06±0.01%. The drug release from the formulations over a 24 h study was found to be 80%±0.09 to 95%±0.06. The maximum desirability was found to be 0.91. The optimum formulation showed mean particle size of 425.8nm and a zeta potential of -45mV. SEM results revealed slightly agglomerated particles with uneven surfaces. The ex-vivo skin permeation of NLC optimized patch formulation exhibited a higher flux and permeability coefficient in comparison to the pure drug patch formulation and marketed gel (2.5%w/w) FTIR spectra assured the chemical and physical compatibility.
Conclusion: Transdermal delivery of ketoprofen via NLCs would be a promising approach for improving the skin permeation.

Anahtar Kelimeler

Ketoprofen, permeation, NLC, Skin, yağlar, optimizasyon, Ex-vivo, Flux

Kaynakça

• Reference1 Tamjidi F, Shahedi M, Varshosaz J, Nasirpour A. Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules. Innov Food Sci Emerging T. 2013; 19:29-43.http://dx.doi.org/10.1016%2Fj.ifset.2013.03.002
• Reference2 Ghasemiyeh P and Mohammadi-Samani S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages, and disadvantages.Res Pharm Sci. 2018; 13(4):288–303. https://doi.org/10.4103/1735-5362.235156
• Reference3 Jain S, Patel N, Shah MK, Khatri P, Vora N. Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. J Pharm Sci. 2017; 106(2):423-45.https://do.org/10.1016/j.xphs.2016.10.001
• Reference4 Chaudhary H, Kohli K, Kumar V. Nano-transfersomes as a novel carrier for transdermal delivery. Int J Pharm. 2013; 454(1):367-80.https://doi.org/10.1016/j.ijpharm.2013.07.031
• Reference5 Zhou X, Hao Y, Yuan L, Pradha. NS, Shrestha K, Pradhan O, et al. Nano-formulations for transdermal drug delivery: a review. Chin Chem Lett. 2018 29;(12):1713-24.https://doi.org/10.1016/j.ijpharm.2013.07.031
• Reference6 Reynolds JEF. Martindale The Extra Pharmacopoeia. 30th ed. London: The pharmaceutical Press;21-22, 1993.
• Reference7 Manikkath J, Manikkath A, Shavi GV, Bhat K, Mutalik S. Low-frequency ultrasound and PAMAM dendrimer facilitated transdermal delivery of ketoprofen. J Drug Deliv Sci Technol. 2017; 41:334-43.https://doi.org/10.1016/j.jddst.2017.07.021
• Reference8 Patwekar SL, Pedewad SR, Gattani S. Development and evaluation of nanostructured lipid carriers-based gel of isotretinoin. Part Sci Technol. 2018; 36(7):832-43.https://doi.org/10.1080/02726351.2017.1305026
• Reference9 Ashwini M, Sudhee P, Sogali B. Custom design perspective in the process parameter optimization of nano lipid carriers. Int J Appl Pharm. 2020:12(6), 198–208. https://doi.org/10.22159/ijap.2020v12i6.39565
• Reference10 Subramanyam B, Siddiq ZH, Nagoor NH. Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations. J Nanoparticle Res. 22(6): 141doi:10.1007/s11051-020-04848-0
• Reference11 Ramkanth S, Chetty CM, Sudhakar Y, Thiruvengadarajan VS, Anitha P, Gopinath C. Development, characterization and in vivo evaluation of proniosomal based transdermal delivery system of Atenolol. Future J Pharm Sci.2018;4(1):80-7.https://doi.org/10.1016/j.fjps.2017.10.003
• Reference12 Fan X, Chen J, Shen Q. Docetaxel–nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery. Int J Pharm. 2013;458(2):296-304.https://doi.org/10.1016/j.ijpharm.2013.10.036
• Reference13 Nair HA, Soni DM. Optimization of formulation parameters for preparation of docetaxel loaded nanostructured lipid carriers. Int J Pharm Sci Res. 2015; 6:2846-57.http://dx.doi.org/10.13040/IJPSR.0975-8232.6(7).
• Reference14 Souto EB, Müller RH. SLN and NLC for topical delivery of ketoconazole. J Microencapsul. 2005 ;22(5):501-10. https://doi.org/10.1080/02652040500162436
• Reference15 Patel RP, Patel G, Patel H, Baria A. Formulation and evaluation of transdermal patch of aceclofenac. Res J Pharma Dosage Forms Technol. 2009;1(2):108-15.http://dx.doi.org/10.5138/ijdd.2009.0975.0215.01005
• Reference16 Phatak AA, Chaudhari PD. Development and evaluation of nanostructured lipid carrier (NLC) based topical delivery of an anti-inflammatory drug. J Pharm Res. 2013;7(8):677-85.http://dx.doi.org/10.1016/j.jopr.2013.08.020
• Reference17 PMennini N, Cirri M, Maestrelli F, Mura P. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation. Int J Pharm. 2016; 30;515(1-2):684-91.https://doi.org/10.1016/j.ijpharm.2016.11.013
• Reference18 PZhai Y, Yang X, Zhao L, Wang Z, Zhai G. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation. Int J Pharm. 2014;471(1-2):103-11.https://doi.org/10.1016/j.ijpharm.20